Response to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: individual participant data analysis | The BMJ

https://www.bmj.com/content/378/bmj-2021-067606

Joseph Thornton

Published by Joseph Thornton MD

Teacher, Clinical Supervisor, [AIdvisor] Retired Clinical Associate Professor, Psychiatry, University of Florida Affiliation is for identification only. All content and opinions are my own.

Leave a comment